The present study also confirmed that BRCA1/2-mutated tumors showed a higher incidence of contralateral breast recurrence compared to non-mutated tumor (non-mutated versus BRCA1/2-mutated tumors: 4.9% vs. 26.0%, p < 0.001). The gene discussed is BRCA1; the disease is neoplasm.